In what can alter the course of cancer treatment in the near future, researchers have found a compound that appears to pinpoint all of the malignant cells in a patient's body.
The twist is that the compound's main ingredient is a molecule that is found in the sting of a deadly scorpion.
The compound called chlorotoxin is found in the venom of the death stalker scorpion known as leiurus quinquestriatus.
It gives malignant cells a bright fluorescent sheen so surgeons can easily spot them, wired.com reported.
"A scorpion-venom concoction that makes tumours glow sounded almost too outlandish to be true in the beginning. But with generous donations from individuals, the fluorescent scorpion toxin is now in Phase I clinical trials," informed Jim Olson from the renowned Seattle-based Fred Hutchinson Cancer Research Centre that developed the technique, called "Tumour Paint".
Scorpion venoms are cocktails of numerous individual toxins that attack different targets within a victim's body.
Olson and his team found that chlorotoxin did not attach just to brain tumours -- it grabbed onto all sorts of cancers, from those that affect the skin to those that destroy the lungs.
In lab experiments, Olson began to inject fluorescent-tipped chlorotoxin into mice -- the compound lit up cancer cells that no other technology could identify.
In one instance, the chlorotoxin illuminated a clump of just 200 malignant cells that were burrowed deep within a wad of fat.
"That was the point we learned that the technology was far more sensitive than an MRI," Olson was quoted as saying.
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
